Becton Dickinson & Co (BDX)
234.43
+2.28
(+0.98%)
USD |
NYSE |
Jan 08, 16:00
234.25
-0.18
(-0.08%)
Pre-Market: 09:12
Becton Dickinson SG&A Expense (Quarterly): 1.256B for Sept. 30, 2024
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Merit Medical Systems Inc | 99.64M |
| Boston Scientific Corp | 1.562B |
| Abbott Laboratories | 2.895B |
| Baxter International Inc | 754.00M |
| ResMed Inc | 238.98M |